These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 4578364)

  • 21. Lipid peroxidative damage in the erythrocytes and elevation of serum LDL-cholesterol, apolipoprotein-B, ferritin and uric acid with age and in coronary heart disease patients.
    El-Gebali HH; Tahir SA; Haider SS; El-Fakhri MM
    Saudi Med J; 2000 Feb; 21(2):184-9. PubMed ID: 11533779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.
    Br Heart J; 1978 Oct; 40(10):1069-118. PubMed ID: 361054
    [No Abstract]   [Full Text] [Related]  

  • 23. The Lipid Research Clinics Coronary Primary Prevention Trial. Results of 6 years of post-trial follow-up. The Lipid Research Clinics Investigators.
    Arch Intern Med; 1992 Jul; 152(7):1399-410. PubMed ID: 1627020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clofibrate trial--the lipid hypothesis retested.
    Med J Aust; 1979 Jun; 1(11):490-1. PubMed ID: 381862
    [No Abstract]   [Full Text] [Related]  

  • 25. Do risk factors change in men at high risk of coronary heart disease? Observations on the effect of health promotion in primary care.
    Roderick PJ; Brennan PJ; Meade TW
    J Cardiovasc Risk; 1995 Aug; 2(4):353-7. PubMed ID: 8536154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Will serum lipid lowering treatment reduce the incidence of coronary heart disease?
    Vessby B; Lithell H; Boberg J
    Artery; 1981; 9(5):372-81. PubMed ID: 7032466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A cooperative trial in the primary prevention of ischaemic heart disease using clofibrate: some statistical aspects.
    Heady JA
    Control Clin Trials; 1981 May; 1(4):383-92. PubMed ID: 7261629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clofibrate, serum enzymes, and muscle pain.
    Smith AF; Macfie WG; Oliver MF
    Br Med J; 1970 Apr; 2(5701):86-8. PubMed ID: 5420239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood pressure, cigarette smoking and heart attack in the WHO co-operative trial of clofibrate.
    Green KG; Heady A; Oliver MF
    Int J Epidemiol; 1989 Jun; 18(2):355-60. PubMed ID: 2767848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clofibrate and the primary prevention of ischaemic heart disease.
    Br Med J; 1978 Dec; 2(6152):1585-6. PubMed ID: 728731
    [No Abstract]   [Full Text] [Related]  

  • 32. Cooperative clofibrate trial.
    Vaisrub S
    JAMA; 1979 Jun; 241(24):2638. PubMed ID: 374769
    [No Abstract]   [Full Text] [Related]  

  • 33. The cardiovascular disease programme of WHO/EURO. A critical review of its first 12 years.
    Lamm G
    Eur Heart J; 1981 Aug; 2(4):269-80. PubMed ID: 7028485
    [No Abstract]   [Full Text] [Related]  

  • 34. Letter: Clofibrate in prevention of ischaemic heart-disease.
    Chakrabarti R; Meade TW
    Lancet; 1975 Apr; 1(7910):799. PubMed ID: 48019
    [No Abstract]   [Full Text] [Related]  

  • 35. Interpretation of clofibrate trial.
    Green KG
    Lancet; 1984 Nov; 2(8411):1095-6. PubMed ID: 6150164
    [No Abstract]   [Full Text] [Related]  

  • 36. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate.
    Miettinen M; Turpeinen O; Karvonen MJ
    Br Heart J; 1979 Sep; 42(3):370-1. PubMed ID: 508466
    [No Abstract]   [Full Text] [Related]  

  • 37. Clofibrate in prevention of ischaemic heart-disease.
    Dinçol K; Ozkan E; Ekmekçi A
    Lancet; 1975 Oct; 2(7939):813-4. PubMed ID: 78173
    [No Abstract]   [Full Text] [Related]  

  • 38. Trial of clofibrate.
    St John-Brooks WH
    Br Med J; 1972 Mar; 1(5802):750. PubMed ID: 4552467
    [No Abstract]   [Full Text] [Related]  

  • 39. Clofibrate and coronary heart disease.
    Med J Aust; 1972 Jan; 1(4):145-7. PubMed ID: 4551814
    [No Abstract]   [Full Text] [Related]  

  • 40. WHO clofibrate/cholesterol trial: clarifications.
    Fowler PB
    Lancet; 1993 Jan; 341(8840):314-5. PubMed ID: 8093961
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.